Amgen’s Imdelltra granted FDA accelerated approval to treat small cell lung cancer
More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year
More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year
It is hoped that a once-weekly treatment option could lead to improved adherence
The company will gain access to two treatments for atopic dermatitis
More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year
AMR could cause an estimated ten million deaths every year by 2050 unless action is taken
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
May 8, 2024 | Appointments
Wickersham recently led Gilead’s liver disease and COVID-19 business unit in the US
Read MoreApr 23, 2024 | Thought Leadership
By Jake Crute
Read MoreApr 22, 2024 | Thought Leadership
By Phil Streit
Read MoreApr 17, 2024 | Appointments
Dunford recently served as executive creative director at TBWA\WorldHealth
Read MoreMay 20, 2024 | Intelligence
Iona Everson from PMGroup spoke to Ioana Parsons, general manager of Ipsen UK and Ireland, about her career path and her experiences working in pharma
Read MoreMay 7, 2024 | Intelligence
Why understanding all aspects of the patient journey is imperative to successful clinical research
Read MoreMay 2, 2024 | Intelligence
Looking at some of the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK
Read MoreApr 30, 2024 | Intelligence
Research has long shown a strong connection between disease and the gut microbiome
Read MoreApr 25, 2024 | Intelligence
With 14 million people in Europe expected to suffer from Alzheimer’s and other forms of dementia by 2030, the race is on to find a treatment to not only slow its course, but even prevent the development of the disease
Read MoreApr 24, 2024 | Intelligence
PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access
Read MoreMay 20, 2024 | Medscape Education Global|Publications, impact, medical education
The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters …
May 17, 2024 | Medscape Education Global|CME, Education, Nursing, medical education
Nurse education is powerful and makes an impact.
May 15, 2024 | Medscape Education Global|Women in healthcare, daretothinkrare, rare disease
Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there …
May 7, 2024 | Mtech Access|GP contract, Market Access, NHS, NHS Whispers, Operational Planning Guidance, primary care
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract …
May 3, 2024 | Innovative Trials|Patient Retention, clinical trials, patient engagement, patient recruitment, pharmaceutical industry
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
May 16, 2024 | Onyx Health|HCP engagement, MedEd, healthcare communications, medical education
Onyx Health’s Head of Medical Education, Sarah Seilly, explains our approach to MedEd and the benefits of tailoring your own
May 7, 2024 | Mednet Group|AI, Innovation, Project Management, artificial intelligence, thought leadership
Explore the ways we’re adapting to work with AI, not against it
May 2, 2024 | Impetus Digital|Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
April 30, 2024 | Mtech Access|AMCP, Health Economics, ICER, US healthcare, USA, health economic evaluation
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight …
April 24, 2024 | Research Partnership|Syndicated, market research, oncology, therapy watch
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a …
May 9, 2024 | Impetus Digital | DOL, HCP advisor, HCP engagement, Healthcare Events, Healthcare Meetings, Impetus Digital, KOL, Pharma meetings, Pharma tips, Pharma trends, Pharme events, Virtual advisory boards, advisor engagement, virtual meetings
Account Specialist - Respiratory - Kent & Medway
Primary Care Liaison Manager - Yorkshire / North East
Diabetes Account Specialist - Derby/Notts/Lincs
Integrated Care Specialist - CV/Metabolic - Manchester
Integrated Care Specialist - CV/Metabolic - Cheshire/Merseyside